You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Figure TDI-2. New and all clients entering treatment by primary drug: heroin, cocaine, cannabis, other stimulants, other drugs in 2007 in 25 EU Member States [see all figures in this series...]
Part (ii) All clients
Notes:
<+>Countries included: Belgium, Bulgaria, Czech Republic, Denmark, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, Netherlands, Austria, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, UK.Spain and Malta: last available data are from 2006.
Belgium: last data available 2005.
Portugal: data available only on new clients; data on new clients were used in Figure 2; therefore the number of all clients for Portugal is underestimated.
Latvia: data available on all client only refer to inpatient treatment; therefore the number of all clients for Latvia is underestimated.
Related links:
Statistical bulletin 2008: none
See also ‘General notes for interpreting data’ on the Explanatory notes and help page
See also Table TDI-102 and Figure TDI-1 part (ii)
Sources:
Reitox national reports 2008 - TDI - All clients
(see the help page for information about formats etc.)